Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
09/2010
09/07/2010US7790465 Methods, systems and computer programs for assessing CHD risk using adjusted LDL particle number measurements
09/07/2010US7790464 Blood hemolysis analyzer
09/07/2010US7790463 Using chemokine profile (RANTES) as evaluative tool in predicting of pre-term pregnancy complications
09/07/2010US7790461 Nano-emulsion technology for drug elution
09/07/2010US7790439 For detection of concentration in solutions; immunochromatography
09/07/2010US7790428 Essential fungal polypeptide, CaYDR341c, and methods of use thereof
09/07/2010US7790420 Screening for expression of soluble protein via modification of peptide substrates; novel reporter molecules
09/07/2010US7790414 Methods for producing antibodies
09/07/2010US7790408 Methods and compositions using stearoyl-CoA desaturase to identify triglyceride reducing therapeutic agents
09/07/2010US7790407 Using Sal-like 4 gene (SALL4) specific immunoglobulin as evaluative/prognostic tool in diagnosis of acute myeloid leukemia (AML)
09/07/2010US7790406 Grating-based sensor combining label-free binding detection and fluorescence amplification and readout system for sensor
09/07/2010US7790405 Solution phase biopanning method using engineered decoy proteins
09/07/2010US7790404 Excitatory glycine receptors and methods
09/07/2010US7790403 Methods for predicting preganancy outcome in a subject by hCG assay
09/07/2010US7790402 Fetuin-A as a biomarker for multiple sclerosis
09/07/2010US7790401 Methods for detection of immunosuppressant drugs
09/07/2010US7790400 Delta-9-tetrahydrocannabinol detection method
09/07/2010US7790399 Using epstein-barr virally transformed human B cell lines as bioreactors for Fc receptor specific immunoglobulins
09/07/2010US7790398 Method for determining effective parathormone activity in a sample
09/07/2010US7790397 Using C-reactive protein, interleukin-6, brain natriuretic peptide, troponin-T and/or troponin-I expression profiles as evaluative tools in determining outcomes associated with cardiovascular disorders
09/07/2010US7790396 Methods and compositions for the treatment of psychotic disorders through the identification of the SULT4A1-1 haplotype
09/07/2010US7790394 Methods of analyzing a biological sample
09/07/2010US7790389 Antireflective coatings for high-resolution photolithographic synthesis of DNA arrays
09/07/2010US7790384 Using huntingtin Interacting Protein 1 (HIP1) expression profiles as evaluative tools in diagnosis and treatment of lymphoma and brain cancers
09/07/2010US7790379 Mapping of proteins along chromatin by chromatin cleavage
09/07/2010US7790377 Identification of safe, natural compounds that interfere with survival and development; testing action on famesoid X activated receptor (FXR) and/or ecdysone receptor (EcR) mediated transcription
09/07/2010US7790376 PREFERENTIAL CLASSIFICATON BETWEEN CANCER CELLS; OBTAIN SAMPLE, MONITOR SAMPLE FOR PREFERENTIAL ENZYMATIC ACTIVITY, EVALUATE DIFFERENTIATED CELLS; for of detecting presence or absence or level of a polynucleotide sequence encoding heparanase in a biological sample
09/07/2010US7790367 having determined antigen specificity, and having a variable fragment which is obtainable from a camelid heavy-chain immunoglobulin having two heavy polypeptide chains capable of recognizing and binding an antigen and which is further devoid of polypeptide light chains
09/07/2010US7790364 Compositions and methods for high throughput screening of pharmacological chaperones
09/07/2010US7790363 Diagnostic test for vitamin B12
09/07/2010US7790362 Prostaglandin E1 as platelet inhibitor; signal transduction; solid phase synthesis; kits
09/07/2010US7790186 synthetic P. vivax circumsporozoite protein useful as a diagnostic reagent, for antibody production, and as a vaccine protective against infection with any strain of P. vivax; malaria vaccine
09/07/2010US7790166 Anti-CD40 antibodies capable of blocking B-cell activation
09/07/2010US7790164 Fab proteins; anticancer agents; immunoglobulins; gene expression inhibition; kits
09/07/2010US7790162 Compositions and uses thereof for identifying and targeting provasopressin-expressing cancer cells
09/07/2010US7790157 Methods of modulating CARK protein activity
09/07/2010US7790111 Osmotic reaction detector for detecting biological and non-biological reactions
09/07/2010US7790109 polydimethylsiloxane upper plates; fluoresence; polymerase chain reactions
09/07/2010US7790108 Assembling container for use in homogenization of coated and sedimenting particles
09/07/2010US7790106 for blood glucose determination
09/07/2010US7790006 Free chlorine sensor
09/07/2010US7788970 Wireless sensor probe
09/07/2010CA2450871C Assay for identifying inhibitors of hiv rt dimerization
09/07/2010CA2437618C Urine assay for ovarian reserve
09/07/2010CA2348415C Method for gold deposition
09/07/2010CA2179895C Marker for pathologies comprising an auto-immune reaction and/or for inflammatory diseases
09/05/2010CA2665771A1 Method and kit for effecting screening and immunogenic treatment using crt and/or erp57 translocation
09/04/2010CA2695345A1 Performance test methods for cookware
09/03/2010CA2695093A1 Method for diagnosing staphylococcal infections
09/02/2010WO2010099543A2 Compositions and methods for detecting oral neoplasm
09/02/2010WO2010099510A2 Amino acid-based compounds, their methods of use, and methods of screening
09/02/2010WO2010099489A2 Ovarian cancer methylome
09/02/2010WO2010099486A1 Solution phase homogeneous assays
09/02/2010WO2010099479A1 Non separation assays with selective signal inhibitors
09/02/2010WO2010099477A2 Polypeptide structural motifs associated with cell signaling activity
09/02/2010WO2010099455A2 Glass substrate orientation inspection methods and systems for photo voltaics production
09/02/2010WO2010099446A1 Systems and methods using photoluminescent nanostructure based hydrogels
09/02/2010WO2010099432A2 Recognition of cyp2e1 epitopes
09/02/2010WO2010099384A1 HYPER IgE ANIMAL MODEL WITH ENHANCED IMMUNOGLOBULIN HEAVY CHAIN CLASS SWITCHING TO Cε
09/02/2010WO2010099364A2 Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
09/02/2010WO2010099363A1 Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
09/02/2010WO2010099328A2 Spatially-selective reflector structures, reflector disks, and systems and methods for use thereof
09/02/2010WO2010099318A1 Physiologic sample preparation for nanosensors
09/02/2010WO2010099313A1 Cgm-based prevention of hypoglycemia via hypoglycemia risk assessment and smooth reduction insulin delivery
09/02/2010WO2010099203A1 Methods and device for non-destructive measurement of relative water content in plants
09/02/2010WO2010099199A1 Detection of complexes of tau and amyloid
09/02/2010WO2010099184A1 Antigenic approach to the detection and isolation of microparticles associated with fetal dna
09/02/2010WO2010099169A2 A novel in vitro hiv-1 latency model for screening reactivation agents of hiv-1
09/02/2010WO2010099154A2 Analyte sensor offset normalization
09/02/2010WO2010099138A2 Methods for the identification of agents that inhibit mesenchymal-like tumor cells or their formation
09/02/2010WO2010099137A2 In situ methods for monitoring the emt status of tumor cells in vivo
09/02/2010WO2010099108A2 Multiplexing derivatized anayltes using mass spectroscopy
09/02/2010WO2010099019A1 Antibodies containing therapeutic tpo/epo mimetic peptides
09/02/2010WO2010099003A2 Compositions and methods for visualizing and eliminating cancer stem cells
09/02/2010WO2010098851A2 System and method of temperature adjustment and control of food processing/dispensing system or apparatus
09/02/2010WO2010098613A2 Tm7sf3 composition for diagnosing liver cancer, diagnostic kit containing anti-tm7sf3 antibodies, and pharmaceutical composition for preventing or treating liver cancer
09/02/2010WO2010098528A1 Biosensor device and sensing method allowing real-time detection of physical changes in biological materials
09/02/2010WO2010098502A1 Imaging diagnostic agent and extracorporeal diagnostic agent for incurable neurological diseases
09/02/2010WO2010098471A1 Immunization method using cancer cell
09/02/2010WO2010098166A1 Cell adhesion inhibitor and use thereof
09/02/2010WO2010098105A1 Incubated state evaluating device, incubated state evaluating method, incubator, and program
09/02/2010WO2010098010A1 Cure degree evaluation method, cure degree evaluation sheet and cure degree evaluation system for active energy ray-curable resin composition
09/02/2010WO2010097806A1 Probes and primers for detection of chikungunya
09/02/2010WO2010097803A1 Probes and primers for detection of malaria
09/02/2010WO2010097785A1 A method for the selective concentration of a specific low abundance biomolecule
09/02/2010WO2010097782A1 A water fraction measuring sensor and method
09/02/2010WO2010097747A2 Connection system for sensor cartridge
09/02/2010WO2010097631A1 Biomarkers
09/02/2010WO2010097630A1 Biomarkers
09/02/2010WO2010097625A1 Diagnostic method and kit
09/02/2010WO2010097600A1 Improved methods for identification
09/02/2010WO2010097591A1 Methods for identification
09/02/2010WO2010097584A1 Dna damage repair assay
09/02/2010WO2010097553A2 Method for diagnosing vasculitis
09/02/2010WO2010097508A1 Methods and apparatus for detecting ethanol
09/02/2010WO2010097443A1 A diagnostic in-vitro method or assay for diagnosing chronic obstructive pulmonary disease (COPD)
09/02/2010WO2010097367A1 Radiolabelled pde10 ligands
09/02/2010WO2010097266A1 Method and arrangement for inhibiting a chemical reaction of substances in a liquid before a measurement
09/02/2010WO2010097186A1 Use of s-erbb-3 as a marker for cancer
09/02/2010WO2010097182A1 Method for in vivo imaging of lymph node lymphangiogenesis by immuno-positron emission tomography and markers therefore